Press Releases
Press Releases
| Date | Press Releases | Topic |
|---|---|---|
| Sep 27, 2006 |
Lax Oversight of Genetic Tests Better oversight of genetic testing laboratories by the Centers for Medicare and Medicaid Services (CMS) is “critical to ensuring the quality of genetic testing in the United States,” and failure to provide it “poses a risk to the public’s health,” according to a Petition for Rulemaking submitted today to CMS Administrator Mark McClellan by the Genetics and Public Policy Center, Public Citizen, and Genetic Alliance. |
|
| Aug 8, 2006 |
Improvement Needed in Genetic Testing Oversight In recent months many health-related organizations have joined in calling on the Centers for Medicare and Medicaid Services (CMS) to end years of delay in assuring the safety and accuracy of genetic testing. In separate letters to CMS Administrator Mark McClellan, members of Genetic Alliance and a coalition of women’s health groups urged the agency to issue a proposed rule to create a genetic testing specialty under the Clinical Laboratory Improvement Amendments (CLIA) of 1988. |
|
| Aug 4, 2006 |
New Bill Could Jumpstart The Setting of Sound Genetic Public Policy Sen. Barack Obama (D-IL) introduced legislation to improve development and appropriate use of genetic tests in the United States, the Genetics and Public Policy Center has learned. "The Obama bill accelerates advances in the beneficial applications of genetic technologies to human health, while ensuring appropriate safeguards for the quality of genetic testing," says Center Director Kathy Hudson. |
|
| Jul 27, 2006 |
Oversight Gaps for Genetic Testing Pose Risks to Public Health At the invitation of the Senate Special Committee on Aging, Genetics and Public Policy Center Director Kathy Hudson testified on Thursday, July 27 as part of the hearing "At Home DNA Tests: Marketing Scam or Medical Breakthrough?" Hudson made the case that poor oversight of genetic testing has led to a situation in which "there is no way for a consumer to distinguish between the dubious and the decent" genetic tests and the laboratories that perform them. |
|
| Dec 12, 2005 |
The Pew Charitable Trusts Supports U.S. Pandemic Planning Project In response to the threat that avian flu could transition into a human pandemic, The Pew Charitable Trusts announced today a $1.5 million investment to ensure that key decision makers at the federal, state and local levels are responsibly developing and executing plans to protect Americans from this or other widespread public health threats. |
|
| Nov 12, 2012 |
America Gets Mixed Score on ''Antibiotics IQ'' Test Nearly nine in 10 Americans recognize that antibiotics are effective treatments for fighting bacterial infections like strep throat, but more than a third mistakenly believe the drugs are also appropriate treatments for viral infections such as the common cold. |
Antibiotic Innovation |
| May 16, 2012 |
Use of Last-Resort Antibiotics Rises in VA Hospitals, National Study Finds To fight the rising number of drug-resistant infections, doctors in Veterans Affairs (VA) hospitals are more frequently turning to last-resort antibiotics, known as polymyxins, which can cause serious kidney damage, according to a new study in the journal PLoS One. |
Antibiotic Innovation |
| Oct 19, 2011 |
Pew Supports Antibiotics Innovation Bill in Senate Sharon Ladin, director of the Pew Health Group’s Antibiotics and Innovation Project, issued the following statement regarding the bipartisan, bicameral Generating Antibiotic Incentives Now (GAIN) Act, introduced today by Sen. Richard Blumenthal (D-Conn.) and Sen. Bob Corker (R-Tenn.). The bill is a companion to H.R. 2182 and contains provisions to incentivize the creation of new antibiotics to combat serious drug-resistant infections. |
Antibiotic Innovation |
| Sep 22, 2011 |
Antibiotics Conference Addresses Lack of New Drugs to Fight Deadly Superbugs Leaders from government, industry, academia, medicine and science today will come together to discuss one of the most pressing health challenges we face: the rising incidence of drug-resistant bacteria and the lack of new antibiotics to fight them. |
Antibiotic Innovation |
| Mar 20, 2013 |
Pew Commends Senators Gillibrand and Feinstein for Working to Shine Light on Antibiotics Practices The Senate Health, Education, Labor and Pensions Committee today adopted the Animal Drug User Fee Act, which failed to include provisions from Senators Kirsten Gillibrand (D-NY) and Dianne Feinstein (D-CA) that would improve the Food and Drug Administration's annual reporting of antibiotic sales for use on industrial farms. |
Antibiotics in Food Animal Production |
| May 15, 2012 |
“Supermoms Against Superbugs” Take Washington by Storm Moms from Maine to Hawaii have come to Washington, D.C., today to press the Obama Administration and Congress to do more to rein in the overuse of antibiotics on America’s industrial farms, a practice that breeds antibiotic-resistant bacteria. |
Antibiotics in Food Animal Production |
| May 10, 2012 |
Chicago Public School Student-Chefs Treat Congress to Chicken Raised without Antibiotics Six high school students from the Chicago Vocational Career Academy served Congress a lunch that features chicken raised without antibiotics, just like much of the chicken now on the menu in public schools back home in Chicago. |
Antibiotics in Food Animal Production |
| Jan 4, 2012 |
Pew Applauds FDA Measure to Preserve Effectiveness of Critical Antibiotics The Pew Campaign on Human Health and Industrial Farming today praised the U.S. Food and Drug Administration (FDA) for limiting the use of cephalosporins in food animal production. |
Antibiotics in Food Animal Production |
| Nov 1, 2011 |
Chicago Public Schools Largest District to Serve Chicken Raised without Antibiotics Chicago Public Schools (CPS) today began serving local chicken raised without antibiotics to students in 473 schools. This development comes on the heels of a fresh chicken purchase direct from the USDA earlier this fall. |
Antibiotics in Food Animal Production |
| Jun 16, 2011 |
Pew Applauds Introduction of Bipartisan Bill in Senate to Preserve Effectiveness of Antibiotics The Pew Campaign on Human Health and Industrial Farming (HHIF) today applauded U.S. Senators Dianne Feinstein (D-Calif.), Susan Collins (R-Maine), Jack Reed (D-R.I.) and Barbara Boxer (D-Calif.) for introducing S. 1211, the Preservation of Antibiotics for Medical Treatment Act of 2011 (PAMTA). The bill amends the Federal Food, Drug, and Cosmetic Act to withdraw seven classes of antibiotics critical for treating infections in humans from use on industrial farms unless animals or herds are sick with disease. |
Antibiotics in Food Animal Production |
